Latest

Health and bio · United States · founded 2022

OpenEvidence valuation and IPO status

OpenEvidence is valued at $15B (21 Oct 2026). IPO status: private.

Source tier: ReportedSource: Ars Technica

Latest valuation$15BBasis: primary roundSource tier: ReportedAs of Ars Technica

Information only, not investment advice. Figures are from public sources; tiers show how solid each one is.

About OpenEvidence

AI search and answer tool for doctors, free to clinicians and funded by pharmaceutical and medical advertising.

Valued at $15B as of September 2026 per Wikipedia's summary of this report; round details not checked.

OpenEvidence valuation history

Priced transactions, newest to the right

OpenEvidence valuation historyOpenEvidence valuation history: from $1B (19 Feb 2025) to $15B (21 Oct 2026), 5 data points.$0$5B$10B$15B$20BApr 25Jul 25Oct 252026Apr 26Jul 26Oct 26$15Bprimary round$12Bprimary round$6Bprimary round$3.5Bprimary round$1Bprimary roundOpenEvidence valuation historyOpenEvidence valuation history: from $1B (19 Feb 2025) to $15B (21 Oct 2026), 5 data points.$0$5B$10B$15B$20BApr 25Jul 25Oct 252026Apr 26Jul 26Oct 26$15B$12B$6B
LatestConfirmed or reportedA valuation holds until the next round.
Show the data
OpenEvidence valuation history
DateEventValuationTierSource
primary round$15BSource tier: ReportedArs Technica
primary round$12BSource tier: ReportedThe Economic Times
primary round$6BSource tier: ReportedThe New York Times
primary round$3.5BSource tier: ReportedModern Healthcare
primary round$1BSource tier: ReportedCNBC

Key investors

Sequoia Capital, GV, Kleiner Perkins.

OpenEvidence: quick answers

How much is OpenEvidence worth?

OpenEvidence's latest priced valuation is $15B (21 Oct 2026), according to Ars Technica. We label it reported.

Is OpenEvidence going public?

Status: private.

Who invests in OpenEvidence?

Named investors include Sequoia Capital, GV, Kleiner Perkins.

Sources

  1. Ars Technica. arstechnica.com, Source tier: Reported
  2. The Economic Times. enterpriseai.economictimes.indiatimes.com, Source tier: Reported
  3. The New York Times. nytimes.com, Source tier: Reported
  4. Modern Healthcare. modernhealthcare.com, Source tier: Reported
  5. CNBC. cnbc.com, Source tier: Reported

Related: Isomorphic Labs, Neuralink. Valuation tracker, technical valuation.

Alerts

Anthropic IPO alerts by e-mail

Get an e-mail when Anthropic starts trading.